Profile:
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, widely recognized for its role in managing type 2 diabetes and obesity.
Marketed under the brand name Victoza for diabetes and Saxenda for weight loss, liraglutide mimics the action of GLP-1,
a hormone that stimulates insulin secretion in response to high blood sugar levels.
This mechanism not only aids in lowering blood glucose but also slows gastric emptying and promotes a feeling of satiety, contributing to weight reduction.
In addition to improving glycemic control in patients with type 2 diabetes, liraglutide has shown cardiovascular benefits by
reducing the risk of major adverse cardiovascular events such as heart attack, stroke, or death from cardiovascular causes.
Its administration involves once-daily subcutaneous injection.
It's important to note that while liraglutide offers significant benefits for individuals with type 2 diabetes and those looking to manage their weight effectively;
it may not be suitable for everyone. Potential side effects include nausea, diarrhea, and pancreatitis among others;
hence healthcare providers carefully consider patient history before prescribing this medication.
Reference Quality Standards
Appearance: white powder white powder
Purity(HPLC) ≥98.0%
Single impurity≤1.0%
Acetate content 5.0%~12.0
Water content≤10.0%
Peptide content ≥80.0
Endotoxin≤5EU/mg
Product Forms: Nasal Spray, Injectable Solution, Oral Capsules/Tablets, Solution/Drops
Related peptides: Semaglutide, Dulaglutide, Albiglutide, Exenatide, etc.
Payment method: T/T in advance, Paypal, Western Union, L/C, etc.
Shipping ways: Courier, Air, Sea, Road
Storage Condition: Dry, dark, and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
China
